| VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance (K260282) | bioMerieux, Inc. | 2026-04-15 |
| VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) (K260281) | BIOMERIEUX | 2026-03-26 |
| VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) (K251579) | bioMerieux, Inc. | 2025-08-21 |
| BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) (K251713) | Becton, Dickinson and Company | 2025-08-08 |
| BD Phoenix™ Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL) (K250447) | Becton, Dickinson and Company | 2025-05-19 |
| VITEK COMPACT PRO (K234012) | bioMerieux, Inc. | 2025-03-14 |
| BD Phoenix™ Automated Microbiology System (K250344) | Becton, Dickinson and Company | 2025-03-06 |
| BD Phoenix™ Automated Microbiology System - GN Ciprofloxacin (0.0156–4 µg/mL) (K233986) | Becton, Dickinson and Company | 2024-03-15 |
| VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) (K234000) | bioMerieux, Inc. | 2024-03-11 |
| Colibrí (K232756) | Copan Wasp Srl | 2023-12-27 |
| VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin (K232201) | bioMerieux, Inc. | 2023-10-23 |
| VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (K230864) | bioMerieux, Inc. | 2023-07-05 |
| VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) (K222378) | bioMerieux, Inc. | 2023-06-26 |
| Selux AST System; Model AST Gen 1.0 (K211748) | Selux Diagnostics, Inc. | 2023-04-19 |
| VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (K222430) | Biomerieux Sa, Inc. | 2023-03-09 |
| VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (K223478) | bioMerieux, Inc. | 2023-02-16 |
| VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) (K222073) | bioMerieux, Inc. | 2023-02-09 |
| VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) (K223481) | bioMerieux, Inc. | 2023-02-03 |
| VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin (K220803) | bioMerieux, Inc. | 2023-01-27 |
| Selux AST System; Model AST Gen 1.0 (K211759) | Selux Diagnostics, Inc. | 2023-01-18 |
| VITEK 2 AST-Gram Positive Cefoxitin Screen (K220805) | bioMerieux, Inc. | 2022-10-13 |
| Colibrí System (K220546) | Copan Wasp Srl | 2022-10-05 |
| VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) (K212243) | bioMerieux, Inc. | 2022-08-08 |
| VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (K213899) | bioMerieux, Inc. | 2022-07-12 |
| VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) (K213931) | bioMerieux, Inc. | 2022-06-03 |
| VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) (K214023) | bioMerieux, Inc. | 2022-04-14 |
| VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (K213241) | bioMerieux, Inc. | 2022-02-25 |
| VITEK 2 AST-Gram Positive Linezolid (<=0.5 – >=8 µg/mL) (K212849) | Biomérieux, Inc. | 2022-02-04 |
| VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) (K210287) | bioMerieux, Inc. | 2021-10-28 |
| VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) (K202396) | bioMerieux, Inc. | 2021-09-14 |
| VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) (K211630) | bioMerieux, Inc. | 2021-08-30 |
| VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) (K201675) | bioMerieux, Inc. | 2021-07-09 |
| VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) (K211136) | bioMerieux, Inc. | 2021-06-14 |
| VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) (K193299) | bioMerieux, Inc. | 2020-09-28 |
| LabPro Data Management System (K201405) | Beckman Coulter, Inc. | 2020-08-30 |
| VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) (K200590) | bioMerieux, Inc. | 2020-04-28 |
| VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) (K193572) | bioMerieux, Inc. | 2020-03-13 |
| VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL) (K193567) | bioMerieux, Inc. | 2020-02-14 |
| Vitek Densichek (K192110) | bioMerieux, Inc. | 2019-10-31 |
| VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) (K191766) | bioMerieux, Inc. | 2019-08-05 |
| BD Phoenix Automated Microbiology System – GN Ceftaroline (0.0156-4 µg/mL) (K190905) | Becton, Dickinson and Company | 2019-07-01 |
| VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) (K190616) | bioMerieux, Inc. | 2019-06-06 |
| VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) (K183524) | bioMerieux, Inc. | 2019-03-12 |
| VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) (K183551) | bioMerieux, Inc. | 2019-03-07 |
| VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL) (K183360) | bioMerieux, Inc. | 2019-02-26 |
| VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) (K183415) | bioMerieux, Inc. | 2019-02-20 |
| VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance (K181766) | bioMerieux, Inc. | 2018-12-10 |
| BD Phoenix Automated Microbiology System - BD Phoenix CPO detect - GN (K181665) | Becton, Dickinson and Company | 2018-09-21 |
| BD Phoenix Automated Microbiology System - GN Meropenem-vaborbactam (0.125/8-32/8 ug/mL) (K173523) | Becton, Dickinson and Company | 2018-02-09 |
| BD Phoenix Automated Microbiology System - GN Ceftolozane/tazobactam (0.25/4-32/4 ug/mL) (K173252) | Becton, Dickinson and Company | 2018-01-05 |
| VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL (K172944) | bioMerieux, Inc. | 2017-12-19 |
| VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) (K172731) | bioMerieux, Inc. | 2017-12-08 |
| VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL) (K162737) | bioMerieux, Inc. | 2017-06-21 |
| BD Phoenix Automated Microbiology System - GN Ceftazidime/avibactam (0.25/4- 32/4ug/mL) (K163637) | Becton Dickinson & Company | 2017-03-21 |
| VITEK 2 AST-GN Gentamicin (<=1 – >=16 µg/mL) (K163563) | bioMerieux, Inc. | 2017-03-13 |
| VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) (K161437) | bioMerieux, Inc. | 2017-02-16 |
| VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) (K161510) | bioMerieux, Inc. | 2017-02-13 |
| VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) (K163083) | bioMerieux, Inc. | 2017-02-01 |
| VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) (K163006) | bioMerieux, Inc. | 2017-01-24 |
| VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL) (K161217) | bioMerieux, Inc. | 2017-01-12 |
| VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL) (K161227) | bioMerieux, Inc. | 2016-07-20 |
| VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL) (K152075) | bioMerieux, Inc. | 2016-04-15 |
| BD Phoenix Automated Microbiology System-Ertapenem 0.0625-8 mcg/ml (K151320) | Becton, Dickinson and Company | 2016-01-15 |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTESM - TIGECYCLINE (0.313-4UG/ML) GP (K142170) | Becton, Dickinson and Company | 2014-10-28 |
| VITEK 2 AST GP CEFTAROLINE (K141149) | bioMerieux, Inc. | 2014-06-20 |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAROLINE (0.625-4 UG/ML) (K140468) | Becton, Dickinson and Company | 2014-06-02 |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM TIGECYCLINE (0.25-16 UG/ML) (K132909) | Becton, Dickinson and Company | 2014-02-14 |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- MEROPENEM (0.125-32 UG/ML) (K132674) | Becton, Dickinson and Company | 2013-12-27 |
| VITEK 2 AST ST MEROPENEM (K132507) | bioMerieux, Inc. | 2013-11-15 |
| VITEK 2 AST-ST TIGECYCLINE (K131779) | bioMerieux, Inc. | 2013-10-10 |
| VITEK 2 AST ST MOXIFLOXACIN, VITEK 2 AST STREPTOCOCCUS MOXIFLOXACIN (K132573) | bioMerieux, Inc. | 2013-09-13 |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - VANCOMYCIN (0.5-32 UG/ML) (K131331) | Becton, Dickinson & CO | 2013-07-10 |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- IMIPENEM (0.0625-32 UG/ML) (K123404) | Becton, Dickinson & CO | 2013-06-27 |
| BD PHOENIX AUTOMATED MICROIOLOGY SYSTEM- ERTAPENEM 0.0625-8 UG/ML-GN (K123266) | Becton, Dickinson and Company | 2013-06-26 |
| VITEK 2 GRAM NEGATIVE DOXYCYCLINE (K121546) | bioMerieux, Inc. | 2012-11-20 |
| VITEK 2 AST STREPTOCOCUS VANCOMYCIN (K121100) | bioMerieux, Inc. | 2012-11-19 |
| GRAM POSTITVE CLINDAMYCIN (K122547) | bioMerieux, Inc. | 2012-10-15 |
| VITEK 2 STRPTOCOCCUS CEFTRIAXONE (K122359) | bioMerieux, Inc. | 2012-08-28 |
| VITEK 2 AST-ST CEFOTAXIME (K121863) | bioMerieux, Inc. | 2012-08-16 |
| VITEK 2 AST- GRAM POSTIVE PENICILLIN FOR STREPTOCOCCUS PNEUMONIAE (K113783) | bioMerieux, Inc. | 2012-08-07 |
| VITEK 2 AST-GN PIPERACILLIN/TAZOBACTAM (K113200) | bioMerieux, Inc. | 2012-06-29 |
| VITEK(R) 2 STREPTOCOCCUS TETRACYCLINE (K111893) | bioMerieux, Inc. | 2012-02-28 |
| VITEK 2 STREPTOCOCCUS ERYTHROMYCIN (K111976) | bioMerieux, Inc. | 2012-02-17 |
| VITEK 2 STREPTOCOCCUS TRIMETHOPRIM/SULFAMETHOXAZOLE (K113305) | bioMerieux, Inc. | 2012-02-10 |
| VITEK 2 GRAM NEGATIVE TRIMETHOPRIM/SULFAMETHOAZOLE (K110106) | bioMerieux, Inc. | 2011-11-30 |
| VITEK 2 STREPTOCOCCUS PENICILLIN (K112000) | bioMerieux, Inc. | 2011-10-26 |
| VITEK 2 STREPTOCOCCUS INDUCIBLE CLINDAMYCIN RESISTANCE (K111909) | bioMerieux, Inc. | 2011-10-18 |
| VITEK 2 SYSTEMS (PC) 5.02 SOFTWARE (K103752) | bioMerieux, Inc. | 2011-10-14 |
| VITEK 2 STREPTOCOCCUS LEVOFLOXACIN (K112228) | bioMerieux, Inc. | 2011-10-03 |
| VITEK(R) 2 STREPTOCOCCUS CLINDAMYCIN (K112129) | bioMerieux, Inc. | 2011-09-27 |
| VITEK 2 STRPTOCOCCUS AMPICILLIN (K112075) | bioMerieux, Inc. | 2011-09-15 |
| VITEK 2 AST-ST LINEZOLID (K111599) | bioMerieux, Inc. | 2011-08-12 |
| VITEK 2 GRAM POSITIVE DOXCYCLINE (K093076) | bioMerieux, Inc. | 2010-10-21 |
| DENSICHECK PLUS (K093224) | bioMerieux, Inc. | 2009-11-09 |
| MICROSCAN SYNERGIES PLUS MIC/COMBO PANELS, MODEL B1025 (K092919) | Siemens Healthcare Diagnostics | 2009-10-23 |
| DENSICHEK PLUS (K083536) | bioMerieux, Inc. | 2009-09-11 |
| VITEK 2 GRAM NEGATIVE MEROPENEM (K091899) | bioMerieux, Inc. | 2009-08-14 |
| VITEK 2 GRAM POSITIVE DAPTOMYCIN (K091126) | bioMerieux, Inc. | 2009-06-18 |
| VITEK 2 GRAM NEGATIVE DORIPENEM (K082346) | bioMerieux, Inc. | 2009-03-16 |
| VITEK 2 GRAM POSITIVE ERYTHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE (K083383) | bioMerieux, Inc. | 2009-02-18 |